Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccine
Valentine Gillion, Michel Jadoul, Nathalie Demoulin, Selda Aydın, Arnaud Devresse
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)VaccinationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyCoronavirusVasculitis2019-20 coronavirus outbreakImmune systemVirologyTocilizumabInternal medicineInfectious disease (medical specialty)DiseaseOutbreakRheumatoid arthritisVasculitis and related conditionsDrug-Induced Adverse ReactionsSarcoidosis and Beryllium Toxicity Research